tiprankstipranks
BioInvent International AB (SE:BINV)
:BINV
Sweden Market
BINV
BioInvent International AB
RESEARCH TOOLSreports
Want to see SE:BINV full AI Analyst Report?

BioInvent International AB (BINV) Stock News & Sentiment

2 Followers
BioInvent’s BI-1808 Plus Keytruda Shows Strong Ovarian Cancer Signal in Phase 2a
Premium
Company Announcements
BioInvent’s BI-1808 Plus Keytruda Shows Strong Ovarian Cancer Signal in Phase 2a
9d ago
BioInvent Showcases Promising Ovarian Cancer Antibody BI-1808 in Virtual KOL Event
Premium
Company Announcements
BioInvent Showcases Promising Ovarian Cancer Antibody BI-1808 in Virtual KOL Event
11d ago
BioInvent to Showcase Promising BI-1206 Triplet Data in Relapsed NHL at EHA 2026
Premium
Company Announcements
BioInvent to Showcase Promising BI-1206 Triplet Data in Relapsed NHL at EHA 2026
19d ago
BioInvent’s BI-1808 Delivers Promising CTCL Responses in Phase 2a Trial
Premium
Company Announcements
BioInvent’s BI-1808 Delivers Promising CTCL Responses in Phase 2a Trial
19d ago
BioInvent AGM Backs New Incentive Plan, Share Issue Mandate and Board Changes
Premium
Company Announcements
BioInvent AGM Backs New Incentive Plan, Share Issue Mandate and Board Changes
1M ago
BioInvent Ramps Up Oncology Profile With Dual KOL Events Around ASCO and EHA
Premium
Company Announcements
BioInvent Ramps Up Oncology Profile With Dual KOL Events Around ASCO and EHA
1M ago
BioInvent Narrows Focus on Immuno-Oncology as Q1 Loss Widens and Key Trials Advance
Premium
Company Announcements
BioInvent Narrows Focus on Immuno-Oncology as Q1 Loss Widens and Key Trials Advance
1M ago
More SE:BINV News >

BINV News on the Web

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and BioInvent International AB (OtherBOVNF)
TipRanks News
Bullish
BioInvent’s BI-1808 Plus Keytruda Shows Strong Ovarian Cancer Signal in Phase 2a
TipRanks News
Bullish
BioInvent Showcases Promising Ovarian Cancer Antibody BI-1808 in Virtual KOL Event
TipRanks News
Bullish
BioInvent to Showcase Promising BI-1206 Triplet Data in Relapsed NHL at EHA 2026
TipRanks News
Bullish
BioInvent’s BI-1808 Delivers Promising CTCL Responses in Phase 2a Trial
TipRanks News
Bullish
BioInvent AGM Backs New Incentive Plan, Share Issue Mandate and Board Changes
TipRanks News
Neutral
BioInvent Ramps Up Oncology Profile With Dual KOL Events Around ASCO and EHA
TipRanks News
Bullish
BioInvent Narrows Focus on Immuno-Oncology as Q1 Loss Widens and Key Trials Advance
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:BINV’s Media Buzz Sentiment?
Currently, no data Available
What is SE:BINV’s weekly average amount of articles?
In an average week, 2 articles about SE:BINV are published.
    What is SE:BINV’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    AAgilent
    PHRPhreesia
    ADOAnteoTech Ltd
    OTLKOutlook Therapeutics
    IHHHFIHH Healthcare Bhd
    Showing the stocks with the most bullish news sentiment over the past week